Your browser doesn't support javascript.
loading
Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells.
Ghassemi, Saba; Nunez-Cruz, Selene; O'Connor, Roddy S; Fraietta, Joseph A; Patel, Prachi R; Scholler, John; Barrett, David M; Lundh, Stefan M; Davis, Megan M; Bedoya, Felipe; Zhang, Changfeng; Leferovich, John; Lacey, Simon F; Levine, Bruce L; Grupp, Stephan A; June, Carl H; Melenhorst, J Joseph; Milone, Michael C.
Afiliación
  • Ghassemi S; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. milone@pennmedicine.upenn.edu ghassemi@pennmedicine.upenn.edu.
  • Nunez-Cruz S; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • O'Connor RS; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Fraietta JA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Patel PR; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Scholler J; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Barrett DM; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Lundh SM; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Davis MM; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Bedoya F; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Zhang C; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Leferovich J; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Lacey SF; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Levine BL; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Grupp SA; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • June CH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Melenhorst JJ; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Milone MC; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Cancer Immunol Res ; 6(9): 1100-1109, 2018 09.
Article en En | MEDLINE | ID: mdl-30030295
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Técnicas de Cultivo de Célula / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Guideline / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Técnicas de Cultivo de Célula / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Guideline / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos